A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/66 (2006.01)
Patent
CA 2223874
Methods and compositions for use in inhibiting CMV replication in mammalian patients, wherein an effective amount of TPFA is administered to a patient in need of such treatment. TPFA is demonstrated to be at least as effective as PFA in inhibiting CMV viral replication, while having substantially improved bioavailability relative thereto.
Procédés et compositions servant à inhiber la réplication du cytomégalovirus (CMV) chez des mammifères, lesdits procédés consistant à leur administrer une quantité efficace de trisodium phosphonoformate. On a découvert que ce dernier est au moins aussi efficace que le phosphonoformate pour inhiber la réplication virale de CMV, tandis que sa biodisponibilité est sensiblement améliorée par rapport au phosphonoformate.
Smart & Biggar
The University Of Southern California
LandOfFree
Methods and compositions for inhibiting cytomegalovirus... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for inhibiting cytomegalovirus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for inhibiting cytomegalovirus... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1881949